Philips Intera MR Subject Of Warning Letter For Unapproved Perfusion Claim
This article was originally published in The Gray Sheet
Executive Summary
FDA's recent warning letter to Philips Medical regarding promotion of magnetic resonance (MR) scanners for cardiac perfusion studies is symptomatic of the industry's struggle to find a regulatory pathway to approval for the indication